GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Pre-Tax Income

RDTCF (Rapid Dose Therapeutics) Pre-Tax Income : $-4.20 Mil (TTM As of Nov. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Rapid Dose Therapeutics's pretax income for the three months ended in Nov. 2024 was $-0.98 Mil. Its pretax income for the trailing twelve months (TTM) ended in Nov. 2024 was $-4.20 Mil. Rapid Dose Therapeutics's pretax margin was -271.87%.

During the past 13 years, Rapid Dose Therapeutics's highest Pretax Margin was -239.07%. The lowest was -7886.14%. And the median was -484.42%.


Rapid Dose Therapeutics Pre-Tax Income Historical Data

The historical data trend for Rapid Dose Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Pre-Tax Income Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.00 -1.42 -6.68 -2.83 -3.19

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.66 -1.50 -0.92 -0.81 -0.98

Competitive Comparison of Rapid Dose Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Rapid Dose Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Pre-Tax Income falls into.


;
;

Rapid Dose Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Rapid Dose Therapeutics's Pretax Income for the fiscal year that ended in Feb. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.279+-0.421+-0.49+0+0
=-3.19

Rapid Dose Therapeutics's Pretax Income for the quarter that ended in Nov. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.728+0+-0.249+0+0.001
=-0.98

Pre-Tax Income for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Dose Therapeutics  (OTCPK:RDTCF) Pre-Tax Income Explanation

Rapid Dose Therapeutics's Pretax Margin for the quarter that ended in Nov. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.976/0.359
=-271.87%

During the past 13 years, Rapid Dose Therapeutics's highest Pretax Margin was -239.07%. The lowest was -7886.14%. And the median was -484.42%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Dose Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines

From GuruFocus

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 08-25-2022

Rapid Dose Announces Filing of Corrective Disclosure

By Business Wire Business Wire 04-14-2023

Rapid Dose Announces Board of Director Changes

By Business Wire Business Wire 04-14-2023

Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial Results

By Business Wire Business Wire 02-01-2023

Rapid Dose Announces Proposed Private Placement Financing

By Business Wire Business Wire 06-03-2023